Direkt zum Inhalt
Merck
  • The development and validation of a high performance liquid chromatography (HPLC)/tandem mass spectrometry assay for fenticonazole in human plasma and comparison with an HPLC-UV method.

The development and validation of a high performance liquid chromatography (HPLC)/tandem mass spectrometry assay for fenticonazole in human plasma and comparison with an HPLC-UV method.

Rapid communications in mass spectrometry : RCM (1995-01-01)
W Speed, J M Long, R J Simmonds, T A Enos
ZUSAMMENFASSUNG

A method is described for the determination of fenticonazole in human female plasma. The method utilizes high performance liquid chromatography coupled to atmospheric pressure positive-ion chemical ionization triple quadrupole mass spectrometry. Multiple reaction monitoring is employed for selectivity and sensitivity which enables quantification over the range 0.5-20 ng mL-1 with acceptable precision and accuracy. A comparison is made with an existing HPLC-UV assay and the utility of the technology of combined liquid chromatography and tandem mass spectometry for subnanogram per mL assays is discussed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Fenticonazolnitrat, European Pharmacopoeia (EP) Reference Standard